Clark Williard

444 total citations
11 papers, 270 citations indexed

About

Clark Williard is a scholar working on Genetics, Oncology and Surgery. According to data from OpenAlex, Clark Williard has authored 11 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Clark Williard's work include Estrogen and related hormone effects (6 papers), BRCA gene mutations in cancer (3 papers) and Cancer Risks and Factors (3 papers). Clark Williard is often cited by papers focused on Estrogen and related hormone effects (6 papers), BRCA gene mutations in cancer (3 papers) and Cancer Risks and Factors (3 papers). Clark Williard collaborates with scholars based in United States, Japan and Italy. Clark Williard's co-authors include Aman U. Buzdar, Donald W. Northfelt, James N. Ingle, Richard M. Weinshilboum, Matthew P. Goetz, Mark E. Robson, Gregory A. Kopia, David Snead, George W. Vetrovec and David G. Rizik and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Neurosurgery.

In The Last Decade

Clark Williard

10 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clark Williard United States 8 118 69 68 56 48 11 270
R. S. Mohil India 8 114 1.0× 48 0.7× 79 1.2× 91 1.6× 79 1.6× 12 325
Yvonne Bury United Kingdom 9 145 1.2× 32 0.5× 61 0.9× 78 1.4× 100 2.1× 18 438
H. S. Levin United States 9 74 0.6× 181 2.6× 84 1.2× 107 1.9× 133 2.8× 15 396
H Kawasaki Japan 12 72 0.6× 55 0.8× 69 1.0× 93 1.7× 105 2.2× 32 372
B. Chang United States 6 70 0.6× 118 1.7× 65 1.0× 52 0.9× 117 2.4× 7 392
Lin Guan China 12 46 0.4× 44 0.6× 46 0.7× 48 0.9× 106 2.2× 24 307
Ashok Subramanian United Kingdom 9 58 0.5× 63 0.9× 76 1.1× 23 0.4× 94 2.0× 19 322
Carina Pereira Portugal 13 83 0.7× 63 0.9× 115 1.7× 106 1.9× 163 3.4× 31 453
Wenhui Zhu China 11 18 0.2× 73 1.1× 44 0.6× 22 0.4× 103 2.1× 29 283

Countries citing papers authored by Clark Williard

Since Specialization
Citations

This map shows the geographic impact of Clark Williard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clark Williard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clark Williard more than expected).

Fields of papers citing papers by Clark Williard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clark Williard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clark Williard. The network helps show where Clark Williard may publish in the future.

Co-authorship network of co-authors of Clark Williard

This figure shows the co-authorship network connecting the top 25 collaborators of Clark Williard. A scholar is included among the top collaborators of Clark Williard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clark Williard. Clark Williard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Johansson, Harriet, Valentina Aristarco, Sara Gandini, et al.. (2019). Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer. The Pharmacogenomics Journal. 20(1). 19–26. 9 indexed citations
2.
Dudenkov, Tanda M., James N. Ingle, Aman U. Buzdar, et al.. (2017). SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway. Breast Cancer Research and Treatment. 164(1). 189–199. 17 indexed citations
3.
Williard, Clark. (2016). Bioanalytical Method Transfer Considerations of Chromatographic-Based Assays. Bioanalysis. 8(13). 1409–1413. 1 indexed citations
4.
Ingle, James N., Krishna R. Kalari, Aman U. Buzdar, et al.. (2014). Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole. Steroids. 99(Pt A). 32–38. 33 indexed citations
5.
Williard, Clark, et al.. (2014). The importance of chromatographic resolution when analyzing steroid biomarkers. Steroids. 99(Pt A). 45–48. 7 indexed citations
6.
Dudenkov, Tanda M., James N. Ingle, Aman U. Buzdar, et al.. (2014). Genes associated with serum estrone, estrone conjugates, and androstenedione concentrations in postmenopausal women with estrogen receptor-positive breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 593–593. 3 indexed citations
7.
Bennett, Daniel, Jacqueline A. Gibbons, Roelof Mol, Yoshiaki Ohtsu, & Clark Williard. (2013). Validation of A Method for Quantifying Enzalutamide and its Major Metabolites in Human Plasma by LC–MS/MS. Bioanalysis. 6(6). 737–744. 31 indexed citations
8.
Liu, Mohan, James N. Ingle, Brooke L. Fridley, et al.. (2013). TSPYL5 SNPs: Association with Plasma Estradiol Concentrations and Aromatase Expression. Molecular Endocrinology. 27(4). 657–670. 42 indexed citations
9.
Ingle, James N., Aman U. Buzdar, Daniel J. Schaid, et al.. (2010). Variation in Anastrozole Metabolism and Pharmacodynamics in Women with Early Breast Cancer. Cancer Research. 70(8). 3278–3286. 59 indexed citations
10.
Levy, Elad I., Ricardó A. Hanel, Fermin O. Tio, et al.. (2006). Safety and Pharmacokinetics of Sirolimus-eluting Stents in the Canine Cerebral Vasculature: 180 Day Assessment. Neurosurgery. 59(4). 925–934. 17 indexed citations
11.
Vetrovec, George W., et al.. (2005). Sirolimus PK trial: A pharmacokinetic study of the sirolimus‐eluting Bx Velocity stent in patients with de novo coronary lesions. Catheterization and Cardiovascular Interventions. 67(1). 32–37. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026